Exelixis
EXEL
#1760
Rank
C$15.61 B
Marketcap
C$58.01
Share price
-0.71%
Change (1 day)
16.38%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company